Search Results

176 articles with title/keywords/abstract containing biological response modifiers

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Display per page 

New drug therapies and their effect on the skin

Author: Treudler, Regina

Source: Journal der Deutschen Dermatologischen Gesellschaft, Volume 7, Number 7, July 2009 , pp. 623-636(14)

Publisher: Blackwell Publishing

Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill

Authors: Benson, Alexander B.; Moss, Marc; Silliman, Christopher C.

Source: British Journal of Haematology, Volume 147, Number 4, November 2009 , pp. 431-443(13)

Publisher: Blackwell Publishing

Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases

Author: Fandy, Tamer E.

Source: Current Medicinal Chemistry, Volume 16, Number 17, June 2009 , pp. 2075-2085(11)

Publisher: Bentham Science Publishers

Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds

Authors: Montrone, Michele; Martorelli, Debora; Rosato, Antonio; Dolcetti, Riccardo

Source: Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Dru, Volume 9, Number 2, June 2009 , pp. 113-131(19)

Publisher: Bentham Science Publishers

Yeast-Derived β-Glucan in Combination with Anti-Tumor Monoclonal Antibody Therapy in Cancer

Authors: Liu, Jingjing; Gunn, Lacey; Hansen, Richard; Yan, Jun

Source: Recent Patents on Anti-Cancer Drug Discovery, Volume 4, Number 2, June 2009 , pp. 101-109(9)

Publisher: Bentham Science Publishers

From lab to bedside: emerging clinical applications of thymosin α1

Authors: Goldstein, Allan L; Goldstein, Adam L

Source: Expert Opinion on Biological Therapy, Volume 9, Number 5, May 2009 , pp. 593-608(16)

Publisher: Informa Healthcare

Glucans as Biological Response Modifiers

Authors: Novak, M.; Vetvicka, V.

Source: Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Dru, Volume 9, Number 1, March 2009 , pp. 67-75(9)

Publisher: Bentham Science Publishers

Pathophysiology of Sepsis and Recent Patents on the Diagnosis, Treatment and Prophylaxis for Sepsis

Authors: Okazaki, Yasumasa; Matsukawa, Akihiro

Source: Recent Patents on Inflammation & Allergy Drug Discovery, Volume 3, Number 1, January 2009 , pp. 26-32(7)

Publisher: Bentham Science Publishers

β-Glucans, History, and the Present: Immunomodulatory Aspects and Mechanisms of Action

Authors: Novak, M.; Vetvicka, V.

Source: Journal of Immunotoxicology, Volume 5, Number 1, September 2008 , pp. 47-57(11)

Publisher: Informa Healthcare

Defining Novel Targets for Intervention in Rheumatoid Arthritis: An Overview

Author: Malemud, Charles J.

Source: Current Rheumatology Reviews, Volume 4, Number 4, November 2008 , pp. 214-218(5)

Publisher: Bentham Science Publishers

Targeting Cytokines, Chemokines and Adhesion Molecules in Rheumatoid Arthritis

Authors: Malemud, Charles J.; Reddy, Sujana K.

Source: Current Rheumatology Reviews, Volume 4, Number 4, November 2008 , pp. 219-234(16)

Publisher: Bentham Science Publishers

What Animal Models are Best to Test Novel Rheumatoid Arthritis Therapies?

Author: Wooley, Paul H.

Source: Current Rheumatology Reviews, Volume 4, Number 4, November 2008 , pp. 277-287(11)

Publisher: Bentham Science Publishers

Targeted Therapies - Many Ways to (the Peace of) Rome

Authors: Aringer, Martin; Smolen, Josef S.

Source: Immunology, Endocrine & Metabolic Agents - Medicinal Chemistry (Formerly, Volume 8, Number 3, September 2008 , pp. 200-206(7)

Publisher: Bentham Science Publishers

Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling

Authors: Asai, Hirobumi; Iijima, Hiroko; Matsunaga, Kenichi; Oguchi, Yoshiharu; Katsuno, Hidetoshi; Maeda, Koutaro

Source: Cancer Immunology, Immunotherapy, Volume 57, Number 11, November 2008 , pp. 1647-1655(9)

Publisher: Springer

Free Content Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy

Authors: Merwe, Lize; Cloete, Ruben; Revera, Miriam; Heradien, Marshall; Goosen, Althea; Corfield, Valerie; Brink, Paul; Moolman-Smook, Johanna

Source: Human Genetics, Volume 124, Number 1, August 2008 , pp. 57-61(5)

Publisher: Springer

Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis

Authors: Reich, Kristian; Sinclair, Rodney; Roberts, Graeme; Griffiths, Christopher E.M.; Tabberer, Maggie; Barker, Jonathan

Source: Current Medical Research and Opinion, Volume 24, Number 5, May 2008 , pp. 1237-1254(18)

Publisher: Informa Healthcare

HER2 in the Era of Molecular Medicine: A Review

Authors: Callaghan, Karen A.; Ellsworth, Rachel E.; Ellsworth, Darrell L.; Shriver, Craig D.

Source: Current Cancer Therapy Reviews, Volume 4, Number 1, February 2008 , pp. 57-65(9)

Publisher: Bentham Science Publishers

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A